Haematopoietic Stem Cell Lab, Cancer Research UK, London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom.
Best Pract Res Clin Haematol. 2011 Mar;24(1):13-24. doi: 10.1016/j.beha.2010.11.003. Epub 2011 Jan 14.
Enormous confusion still exists in the scientific community regarding the in vivo identity of putative bone marrow (BM) multipotent mesenchymal progenitor cells (MPCs). There is still lack of consensus between laboratories on this issue but recent advancements in this field have shed light on the identity of these cells in humans. However, in mice there are limited and reproducible data available that convincingly define prospectively these cells in vivo. In this review we will critically address: 1) important considerations on how to interpret MPC nomenclature, heterogeneity and differentiation abilities; 2) potential surface antigens that could aid in the isolation of MPC from mouse BM; 3) and their topography and prospective cellular relationship with pericytes, adventitial reticulocytes (ARCs) and vascular smooth muscle cells (VSMCs).
科学界对于骨髓(BM)多能间充质祖细胞(MPCs)的体内身份仍然存在巨大的混淆。在这个问题上,实验室之间仍然缺乏共识,但该领域的最新进展揭示了这些细胞在人类中的身份。然而,在小鼠中,可用的具有说服力的、可重现的数据有限,这些数据能够明确地对这些细胞进行体内鉴定。在这篇综述中,我们将批判性地讨论:1)关于如何解释 MPC 命名法、异质性和分化能力的重要考虑因素;2)可能有助于从小鼠 BM 中分离 MPC 的表面抗原;3)以及它们与周细胞、外膜网状细胞(ARCs)和血管平滑肌细胞(VSMCs)的拓扑结构和潜在的细胞关系。